Emerging markets represent the highest-growth geographic opportunity in diagnostic imaging — procedure volume growth of 8-12% annually in Asia-Pacific, India, Latin America, and the Middle East driven by expanding health insurance coverage, hospital infrastructure investment, and rising chronic disease burden. China is the world's second-largest diagnostic imaging market and the primary battleground for the competition between global OEMs and domestic Chinese manufacturers led by Mindray, United Imaging, and Neusoft.
Topics Covered
• China Imaging Market
• India Market Dynamics
• Southeast Asia
• Middle East and Africa
• Latin America
• Domestic Chinese OEM Competitive Threat
• Global OEM Emerging Market Strategies
• Reimbursement and Health Insurance Expansion
Table of Contents
1. Executive Summary
2. Market Overview
3. China Imaging Market
4. India Market Dynamics
5. Southeast Asia
6. Middle East and Africa
7. Latin America
8. Domestic Chinese OEM Competitive Threat
9. Global OEM Emerging Market Strategies
10. Reimbursement and Health Insurance Expansion
11. Regional Market Analysis
12. Strategic Conclusions and Recommendations
13. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Canon Medical
Esaote
Fujifilm Healthcare
GE HealthCare
Hologic
Mindray
Philips
Samsung Medison
Shimadzu
Siemens Healthineers
